Disposition of 60000 shares by Mva Investors, Llc of Tango Therapeutics at 7.61 subject to Rule 16b-3

TNGX Stock  USD 3.10  0.16  5.44%   
Slightly above 58% of Tango Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tango Therapeutics suggests that many traders are alarmed. Tango Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tango Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Tango Therapeutics Other: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 60000 common stock at 7.61 of Tango Therapeutics by Mva Investors, Llc on 3rd of May 2024. This event was filed by Tango Therapeutics with SEC on 2024-05-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Tango Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Tango Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Tango Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tango Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tango Therapeutics Fundamental Analysis

We analyze Tango Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tango Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tango Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Tango Therapeutics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Tango Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tango Therapeutics stock to make a market-neutral strategy. Peer analysis of Tango Therapeutics could also be used in its relative valuation, which is a method of valuing Tango Therapeutics by comparing valuation metrics with similar companies.

Peers

Tango Therapeutics Related Equities

XLOXilio Development   36.17   
0%
100.0%
STTKShattuck Labs   10.58   
0%
29.0%
GLUEMonte Rosa   6.45   
0%
17.0%
CGEMCullinan Oncology   5.94   
0%
16.0%
MLYSMineralys Therapeutics,   4.31   
0%
11.0%
KYMRKymera Therapeutics   3.88   
0%
10.0%
ARVNArvinas   3.65   
0%
10.0%
STOKStoke Therapeutics   3.36   
0%
9.0%
FHTXFoghorn Therapeutics   3.21   
0%
8.0%
RAPTRAPT Therapeutics   2.47   
0%
6.0%
BDTXBlack Diamond   1.37   
0%
3.0%
CNTBConnect Biopharma   0.11   
0%
1.0%
PASGPassage Bio     
0%
1.0%
RVMDRevolution Medicines   0.00   
0%
0%
EWTXEdgewise Therapeutics   0.06   
1.0%
0%
THRDThird Harmonic   0.37   
1.0%
0%
PLRXPliant Therapeutics   0.68   
1.0%
0%
NRIXNurix Therapeutics   1.05   
2.0%
0%
RLAYRelay Therapeutics   2.35   
6.0%
0%
RLYBRallybio Corp   3.06   
8.0%
0%
TYRATyra Biosciences   3.45   
9.0%
0%

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.